About 3billion
3billion is a company based in Seoul (South Korea) founded in 2016. 3billion has raised $25.69 million across 4 funding rounds from investors including Korean Development Bank, Shinhan Financial Group and Yuanda Financial Holdings. The company has 85 employees as of December 31, 2024. 3billion offers products and services including 3B-GENOME, 3B-EXOME, 3B-VARIANT, 3B-INTERPRETER, and GEBRA™. 3billion operates in a competitive market with competitors including MedGenome, Foundation Medicine, Burning Rock, Zhejiang Nuhui Health Technology and Blueprint Genetics, among others.
- Headquarter Seoul, South Korea
- Employees 85 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name 3Billion, Inc.
-
Annual Revenue
$3.91 M (USD)111.41as on Dec 31, 2024
-
Net Profit
-$4.45 M (USD)-29.06as on Dec 31, 2024
-
EBITDA
-$4.18 M (USD)11.03as on Dec 31, 2024
-
Total Equity Funding
$25.69 M (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
Korean Development Bank
& 11 more
-
Employee Count
85
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of 3billion
3billion is a publicly listed company on the KRX with ticker symbol 394800 in South Korea, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of 3billion
3billion offers a comprehensive portfolio of products and services, including 3B-GENOME, 3B-EXOME, 3B-VARIANT, 3B-INTERPRETER, and GEBRA™.
Provides genome sequencing for rare disease identification and analysis.
Offers exome sequencing to detect variants in rare diseases.
Analyzes genetic variants for disease diagnosis and research.
Interprets genetic data for clinical and research applications.
Facilitates sample preparation for genetic testing processes.
People of 3billion
Unlock access to complete
Funding Insights of 3billion
3billion has successfully raised a total of $25.69M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in 3billion
3billion has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include Korean Development Bank, Shinhan Financial Group and Yuanda Financial Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment services are offered in healthcare and cannabis sectors.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for 3billion
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by 3billion
Investment portfolio details for 3billion
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - 3billion
Detailed financials for 3billion
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
3Billion Comparisons
Peer comparison for 3billion
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of 3billion
3billion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MedGenome, Foundation Medicine, Burning Rock, Zhejiang Nuhui Health Technology and Blueprint Genetics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
DNA sequencing, bioinformatics, and multiomics services are provided.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Personalized cancer diagnostics are developed using genomic big data analysis.
|
|
| Locked | Locked | Locked |
Provider of early cancer screening and testing services
|
|
| Locked | Locked | Locked |
Genetic diagnostics and clinical interpretation for hereditary diseases are provided.
|
Detailed competitors of 3billion
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on 3Billion
Complete news archive for 3billion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about 3billion
3billion was founded in 2016 and raised its 1st funding round 2 years after it was founded.
3billion is headquartered in Seoul, South Korea.
3billion is a funded company, having raised a total of $25.69M across 4 funding rounds to date.
As of Dec 31, 2024, the latest employee count at 3billion is 85.
Annual revenue of 3billion is $3.91M as on Dec 31, 2024.
An AI-driven clinical diagnostic testing platform for rare genetic diseases is provided by 3billion, founded in 2016 in Seoul, South Korea. Next-generation sequencing combined with machine learning and deep learning algorithms is utilized to analyze whole patient genomes for disease-causing mutations. A single test capable of detecting over 4000 rare genetic disorders is being developed within the healthcare technology sector.
3billion's top competitors include Foundation Medicine, MedGenome and Burning Rock.
3billion offers 3B-GENOME, 3B-EXOME, 3B-VARIANT, 3B-INTERPRETER, and GEBRA™.
Yes, 3billion is publicly traded on KRX under the ticker symbol 394800.
3billion has 12 investors. Key investors include Korean Development Bank, Shinhan Financial Group, Yuanda Financial Holdings, Wells Investment, and JW Asset Management.
The ticker symbol of 3billion is 394800 on KRX.